Blood clot drug tested in youngest patients
NCT ID NCT05966740
Summary
This study aimed to collect real-world safety and effectiveness data on Pradaxa pellets, a blood thinner medication, for children under 12 years old with blood clots. It observed children in routine medical care who were already prescribed the medication to treat a clot or prevent a new one. The main goal was to track bleeding risks and see how well the treatment worked in everyday practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
-
Dayton Children's Hospital
Dayton, Ohio, 45404, United States
-
Dell Children's Ascension
Austin, Texas, 78723, United States
-
Indiana Hemophilia & Thrombrosis Center
Indianapolis, Indiana, 46260, United States
-
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, 33701, United States
-
MUSC (Medical university of South Carolina)
Charleston, South Carolina, 29425, United States
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
University of California, San Diego
La Jolla, California, 92093, United States
-
Vanderbilt University
Nashville, Tennessee, 37232, United States
-
Yale University School of Medicine
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.